We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Two medical professionals looking at a computer screen.
Product News

Oncodesign Services Announce Access to ImaginAb’s CD8 ImmunoPET™ Technology

Oncodesign Services announces the execution of a Preclinical License and Supply Agreement with ImaginAb Inc. for the use of their investigational CD8 ImmunoPET™ (89Zr crefmirlimab berdoxam) technology.
OncoPro Tumoroid Culture Medium Kit
Product News

Thermo Fisher Scientific Introduces Tumoroid Culture Medium

Thermo Fisher Scientific has announced the launch of the first commercially available culture medium specifically developed for the expansion of patient-derived cancer organoids, from multiple cancer indications.
Blood cells in a vessel.
Product News

Cleveland Diagnostics Opens New Facility Amid Growing Demand for IsoPSA® Test

Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, has opened a new, state-of-the-art facility.
The winner of 2023 Eppendorf Award for Young European Investigators, Maurice Michel.
Product News

Eppendorf Award for Young European Investigators 2023 Goes to Maurice Michel, Sweden

The independent jury chaired by Prof. Reinhard Jahn selected Dr. Maurice Michel, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden as the winner of the Eppendorf Award for Young European Investigators 2023.
The Avacta logo
Product News

Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase I Clinical Study

Avacta Group plc has announced that the fifth dose escalation cohort in the ALS-6000-101 dose escalation Phase 1 clinical trial to evaluate the safety and tolerability of AVA6000 has been completed successfully.
Blood cells in a vessel.
Product News

Belong.Life Announces Two Studies Based on Real-World Patient Data at ASCO 2023

Belong.Life has announced that the American Society of Clinical Oncology has published two abstracts in its 2023 Annual Meeting Abstract Book based on data aggregated from the Belong Beating Cancer Together app.
Personalis logo
Product News

Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023

Personalis, Inc. has announced it will present new clinical data as scientific posters at the American Society of Clinical Oncology Annual Meeting 2023, which convenes from June 2-6, 2023, in Chicago, Ill.
Oncohost logo.
Product News

OncoHost To Present PROphet® Biomarker Model That Accurately Predicts Clinical Benefit to ICI-Based Treatment

OncoHost has announced that it will give a poster presentation demonstrating the accuracy of its PROphet® biomarker model at the upcoming American Society of Clinical Oncology Annual Meeting, taking place June 2-6, 2023, in Chicago, Illinois.
T cells attacking a cancer cell.
Product News

Efficient Transduction of CAR Into T Cells

AMSBIO announce a new range of high-titer Chimeric Antigen Receptor (CAR) lentivirus that provide high transduction efficiency with long-term, stable expression in resting and actively dividing cells.
The Personalis logo
Product News

Personalis, National Cancer Center Hospital East and Ono Collaborate To Better Predict Immunotherapy Response for Rectal Cancer

Personalis, Inc., National Cancer Center and Ono Pharmaceutical Co., Ltd. have announced they have entered into a collaborative agreement to examine the efficacy and safety of nivolumab, an immune checkpoint inhibitor, for resectable rectal cancer with mismatch repair deficiency.
Advertisement